Assessment of benefit from screening women ages 40 – 49 years: elements of the controversy

By Mélisande Rouger9th March 2020No Comments

By Dr. S A Feig

The debate regarding screening women ages 40-49 began around 1976 and continues today, making it one of the longest and most
heated of all medical controversies.

Breast imaging screening Feig FebMch2020

Mélisande Rouger

Previous PostHow imaging can support healthcare’s circular economy
Next PostUsing Contrast-Enhanced Digital Mammography: evidence and clinical practice

Subscribe to our newsletter and stay updated.

Subscribe now

Adalbert-Stifter-Weg 2 b
85661 Forstinning
Germany

Tel.: +49 1511 15674833

Site Notice
Privacy Policy

DI Europe is not responsible for any error or omission that might occur in the electronic display of product or company data.

Assessment of benefit from screening women ages 40 – 49 years: elements of the controversy

Mélisande Rouger

Previous PostHow imaging can support healthcare’s circular economy

Next PostUsing Contrast-Enhanced Digital Mammography: evidence and clinical practice

Subscribe to our newsletter and stay updated.

Subscribe now